The study published in JAMA Ophthalmology – the first epidemiologic study to home in on eye injuries in pickleball – reviewed ...

This Stony Brook University-based study reviewed how sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like ...

The FDA has approved Epioxa™ HD 0.239% and Epioxa™ 0.177% for use in epithelium-on corneal collagen CXL for the treatment of ...

A more dangerous strain of mpox, a virus that causes painful lesions and flulike symptoms, has been detected in three California residents who had not traveled internationally.

HealthDay News — For cancer survivors, postdiagnosis smoking cessation is associated with improved overall survival, according to a study published in the October issue of the Journal of the National ...

Receiving two doses of inactivated influenza vaccine (IIV) in the first year of influenza vaccination is associated with improved protection for children younger than 3 years versus one dose.

HealthDay News — Two doses of the recombinant zoster vaccine (RZV) are effective in older adults, including immunocompromised adults, according to a study published online Oct. 13 in the Annals of ...

Investigators conducted a large-scale retrospective cohort study of the prevalence and age of onset of retinal detachment and ...

Presenters at the AAO discussed phase 2 clinical trial results evaluating the safety and efficacy of foselutoclax (UBX1325) compared with aflibercept in diabetic macular edema.

Pilocarpine 1.25% can boost distance corrected near visual acuity among other measures, in presbyopic adult eyes with dark irides.

The FDA has expanded the approval of Yuflyma (adalimumab-aaty) and its unbranded version to include the treatment of HS in patients aged 12 years and older and UV in pediatric patients aged 2 years ...

A Long Island resident has tested positive for the chikungunya virus, the first locally acquired case in the US since 2019, New York state health officials announced.